Paper Status Tracking
Contact us
[email protected]
Click here to send a message to me 3275638434
Paper Publishing WeChat

Article
Affiliation(s)

ABSTRACT

Objective: The objective of this study is to evaluate the effectiveness of Nanoone Woman Underwear used in the management of dysmenorrhea. Methods: The purpose is to evaluate the mean change in menstrual pain intensity during menstrual cycles from baseline to after wearing Nanoone Woman Underwear in women with primary dysmenorrhea. The severity of dysmenorrhea pain experienced by subjects will be evaluated on a VAS (visual analogue scale), ranging from zero (no pain) to ten (very severe pain). Effectiveness will be evaluated at baseline and subsequently on study weeks 1-2, 5-6 and 9-10 using a VAS. The primary objective is to evaluate the mean change in menstrual pain intensity at the endpoint visit from baseline. The difference of the mean change in menstrual pain intensity during each menstrual cycle from baseline will also be investigated. Subjects will be asked to use the VAS scoring system to record, on a provided sheet, their experienced menstrual pain level daily during menstrual bleeding for a total of three consecutive menstrual cycles in house. Results: The mean maximum pain level at poster menstrual cycle was more significant lower than at prior menstrual cycle when respective compared with experienced menstrual pain intensity based on the result of statistical analysis. Conclusion: The mean change in maximum pain level at menstrual cycle was significant lower after long wearing Nanoone Woman Underwear in women with primary dysmenorrheal. Therefore, the improvement extent of menstrual pain intensity was more significant after long wearing Nanoone Woman Underwear.

KEYWORDS

Dysmenorrhea, nanoone technology, pain, underwear.

Cite this paper

References

About | Terms & Conditions | Issue | Privacy | Contact us
Copyright © 2001 - David Publishing Company All rights reserved, www.davidpublisher.com
3 Germay Dr., Unit 4 #4651, Wilmington DE 19804; Tel: 1-323-984-7526; Email: [email protected]